Cargando…
Revisiting Anti-tuberculosis Therapeutic Strategies That Target the Peptidoglycan Structure and Synthesis
Tuberculosis (TB), which is caused by Mycobacterium tuberculosis (Mtb), is one of the leading cause of death by an infectious diseases. The biosynthesis of the mycobacterial cell wall (CW) is an area of increasing research significance, as numerous antibiotics used to treat TB target biosynthesis pa...
Autores principales: | Catalão, Maria João, Filipe, Sérgio R., Pimentel, Madalena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6378297/ https://www.ncbi.nlm.nih.gov/pubmed/30804921 http://dx.doi.org/10.3389/fmicb.2019.00190 |
Ejemplares similares
-
Identification of drivers of mycobacterial resistance to peptidoglycan synthesis inhibitors
por: Olivença, Francisco, et al.
Publicado: (2022) -
CRISPRi-mediated characterization of novel anti-tuberculosis targets: Mycobacterial peptidoglycan modifications promote beta-lactam resistance and intracellular survival
por: Silveiro, Cátia, et al.
Publicado: (2023) -
The Mycobacteriophage Ms6 LysB N-Terminus Displays Peptidoglycan Binding Affinity
por: Gigante, Adriano M., et al.
Publicado: (2021) -
Mycobacteriophage Lysis Enzymes: Targeting the Mycobacterial Cell Envelope
por: Catalão, Maria João, et al.
Publicado: (2018) -
Peptidoglycan enzymes of Francisella: Roles in cell morphology and pathogenesis, and potential as therapeutic targets
por: Bachert, Beth A., et al.
Publicado: (2023)